2 employees
Axikin Pharmaceuticals develops small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases.
2008
$3M
from 1 investors over 1 rounds
Axikin Pharmaceuticals, Inc. raised $3M on January 22, 2009
Investors: Sanderling Ventures